CREST 2
CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL (CREST-2)
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Others
- Trial Phase: NA
- Conditions Being Studied: Coronary Artery Disease (CAD)
Study Purpose
This study is designed to compare the incidence of stroke or death between subjects that receive medical management alone and those that receive medical management in combination with Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS). These procedures are performed to treat carotid artery stenosis (narrowing). This is caused by a thickened area called a plaque. Carotid arteries are the main arteries that feed the brain, and narrowing increases the risk of having a stroke. During CEA, the plaque is removed through a surgical cut in the neck. During CAS, a metal device called a stent is placed in the artery to keep it open. The intensive medical management includes treatments for lifestyle factors such as high blood pressure, high cholesterol, and smoking cessation.
Locations
UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
UH St. John Medical Center
29000 Center Ridge Road
Westlake OH, 44145
- UH IRB: SITE00001229
- StudyID: 2015-1603
- ClinicalTrials.gov: NCT02240862
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422